DAT-B 2015 Direct Antiglobulin Test

Size: px
Start display at page:

Download "DAT-B 2015 Direct Antiglobulin Test"

Transcription

1 EVALUATION DAT-B 2015 Direct Antiglobulin Test INSTITUTION: ATTENTION: CAP NUMBER: Kit# 1 KIT INFORMATION: Kit ID: /12/ /16/2015 Next Mailing Date: 2/22/2016 COPIED TO: LAP CAP LEGEND: Exception Reason Codes appearing in this evaluation: <NONE> Reviewed By Date Page 1 of 2

2 DAT-B 2015 Direct Antiglobulin Test Test Method Specimen Your Result Intended Response Your Grade DAT Poly GEL TESTING DAT-04 POSITIVE POSITIVE /12/ /16/2015 DAT-05 POSITIVE POSITIVE DAT-06 DAT IgG GEL TESTING DAT-04 POSITIVE POSITIVE DAT-05 DAT-06 DAT C3d GEL TESTING DAT-04 DAT-05 POSITIVE POSITIVE DAT-06 Page 2 of 2

3 EVALUATION J-C 2015 Transfusion Medicine (Comp) INSTITUTION: ATTENTION: CAP NUMBER: Kit# 1 KIT INFORMATION: Kit ID: /31/ /1/2015 Next Mailing Date: 2/8/2016 COPIED TO: LAP CAP IMPORTANT NOTES: LEGEND: Exception Reason Codes appearing in this evaluation: [26] = Educational challenge. Reviewed By Date Page 1 of 6

4 J-C 2015 Transfusion Medicine (Comp) Test Method Specimen Your Result Intended Response Your Grade ABO Group J-15R GROUP O GROUP O /31/ /1/2015 J-16R GROUP A GROUP A J-17R GROUP AB GROUP AB J-18R GROUP A GROUP A J-19R GROUP O GROUP O Rh Type J-15R RH POSITIVE RH POSITIVE J-16R RH POSITIVE RH POSITIVE J-17R RH POSITIVE RH POSITIVE J-18R RH RH J-19R RH RH Antibody Detection J-15S ANTIBODY DETECTED ANTIBODY DETECTED J-16S ANTIBODY NOT DETECTED ANTIBODY NOT DETECTED J-17S ANTIBODY DETECTED ANTIBODY DETECTED J-18S ANTIBODY NOT DETECTED ANTIBODY NOT DETECTED J-19S ANTIBODY DETECTED ANTIBODY DETECTED Page 2 of 6

5 J-C 2015 Transfusion Medicine (Comp) Test Method Specimen Your Result Intended Response Your Grade Crossmatch Serology J-15S POSITIVE POSITIVE /31/ /1/2015 J-16S J-17S POSITIVE POSITIVE J-18S J-19S C Type J-20R [26] E Type J-20R [26] c Type J-20R POSITIVE [26] e Type J-20R POSITIVE [26] Other Antigens 1 J-20R Anti-K [26] Page 3 of 6

6 J-C 2015 Transfusion Medicine (Comp) /31/ /1/2015 CAP #: Regulated Analyte Test Event Score % Antibody Detection, Unexpected CAP Subspecialty : Unexpected Antibody Det Test Event Score % Test Event Score % J-A 5 / J-B J-C Current Event Cumulative CLIA Performance '88 Performance Interpretation Interpretation Unexpected Antibody Det Page 4 of 6

7 J-C 2015 Transfusion Medicine (Comp) /31/ /1/2015 ABO Group Rh (D) Type CAP #: Regulated Analyte Test Event Score % CAP Subspecialty : ABO Group/Rh Type Test Event Score % Test Event Score % J-A 5 / J-B J-C J-A 5 / J-B J-C Current Event Cumulative CLIA Performance '88 Performance Interpretation Interpretation ABO Group/Rh Type 10/ / / Page 5 of 6

8 J-C 2015 Transfusion Medicine (Comp) /31/ /1/2015 CAP #: Regulated Analyte Test Event Score % Compatibility Testing CAP Subspecialty : Compatibility Testing Test Event Score % Test Event Score % J-A 5 / J-B J-C Current Event Cumulative CLIA Performance '88 Performance Interpretation Interpretation Compatibility Testing Page 6 of 6

9 EVALUATION VM-C 2015 Viral Markers INSTITUTION: ATTENTION: CAP NUMBER: Kit# 1 KIT INFORMATION: Kit ID: /24/2015 9/22/2015 Next Mailing Date: 1/18/2016 COPIED TO: LAP CAP LEGEND: Exception Reason Codes appearing in this evaluation: [35] = Testing not performed on (or indicated for) this specimen type. Reviewed By Date Page 1 of 5

10 VM-C 2015 Viral Markers Test Method Specimen Your Result Intended Response Your Grade HBsAg ABT ARCHITECT i (INTL) VM /24/2015 9/22/2015 VM1-28 VM1-29 VM1-30 VM1-31 HBsAg Neut ABT ARCHITECT i (INTL) VM1-27 CONFIRMED POSITIVE CONFIRMED POSITIVE VM1-28 CONFIRMED POSITIVE CONFIRMED POSITIVE VM1-29 TESTING NOT INDICATED [35] VM1-30 CONFIRMED POSITIVE CONFIRMED POSITIVE VM1-31 TESTING NOT INDICATED [35] Page 2 of 5

11 VM-C 2015 Viral Markers Test Method Specimen Your Result Intended Response Your Grade Anti-HBs ABT ARCHITECT i (INTL) VM /24/2015 9/22/2015 VM1-28 VM1-29 VM1-30 VM1-31 Anti-HBc Total (IgM an ABT ARCHITECT i (INTL) VM1-27 VM1-28 VM1-29 VM1-30 VM1-31 Page 3 of 5

12 VM-C 2015 Viral Markers Test Method Specimen Your Result Intended Response Your Grade Anti-HIV 1/2 ABT ARCHITECT i (INTL) VM /24/2015 9/22/2015 VM1-28 VM1-29 VM1-30 VM1-31 Anti-HCV ABT ARCHITECT i (INTL) VM1-27 VM1-28 VM1-29 VM1-30 VM1-31 Page 4 of 5

13 VM-C 2015 Viral Markers /24/2015 9/22/2015 CAP #: Regulated Analyte Test Event Score % CAP Subspecialty : General Immunology Test Event Score % Test Event Score % Current Event Cumulative CLIA Performance '88 Performance Interpretation Interpretation Alpha-1-Antitrypsin S-A <4> Alpha-Fetoprotein K-A 5 / K-B <4> Antinuclear Antibody S-A <4> Antistreptolysin O S-A <4> Anti-HIV VM-A 5 / VM-B VM-C Complement C3 S-A <4> Complement C4 S-A <4> Hepatitis (HBsAg) Hepatitis (Anti-HBc) VM-A 5 / VM-B VM-C VM-A 5 / VM-B VM-C IgA S-A <4> IgG S-A <4> IgE S-A <4> IgM S-A <4> Rheumatoid Factor S-A <4> Rubella S-A <4> General Immunology 77 20/ <4> Scorecard performance pending future evaluation or may not be applicable due to discontinued testing or use of a waived method. Page 5 of 5

Laboratory Results Summary

Laboratory Results Summary Laboratory Results Summary Laboratory CO1033AI Test event 2 of 3 CAP LAP Number 7181660 Page Print Date 9 / 10 2008/Jul/04 Program Syphilis (SYPH435) Results Deadline 2008/Jun/24 Subscription ID Analyte

More information

VM-A 2011 Viral Markers

VM-A 2011 Viral Markers EVALUATION VM-A 2011 Viral Markers INSTITUTION: ATTENTION: CAP NUMBER: 7181660-01 Kit# 1 KIT INFORMATION: Kit ID: 23929821 1/3/2011 2/8/2011 Next Mailing Date: 9/2011 COPIED TO: LAP CAP LEGEND: Exception

More information

Transfusion Medicine (Comprehensive, Limited) J, J1

Transfusion Medicine (Comprehensive, Limited) J, J1 www.cap.org Transfusion Medicine Analytes/procedures in bold type are regulated for proficiency testing by the Centers for Medicare & Medicaid Services (CMS). Transfusion Medicine (Comprehensive, Limited)

More information

PROFICIENCY TESTING. Clinical Laboratory Improvement Amendments (CLIA) DOs and DON Ts. Brochure # 8

PROFICIENCY TESTING. Clinical Laboratory Improvement Amendments (CLIA) DOs and DON Ts. Brochure # 8 Clinical Laboratory Improvement Amendments (CLIA) Brochure # 8 PROFICIENCY TESTING DOs and DON Ts NOTE: Congress passed the Clinical Laboratory Improvement Amendments (CLIA) in 1988 establishing quality

More information

CLIA APPROVED PROFICIENCY TESTING PROGRAMS ACCUTEST, INC. P.O. Box 999 Westford, Massachusetts (800)

CLIA APPROVED PROFICIENCY TESTING PROGRAMS ACCUTEST, INC. P.O. Box 999 Westford, Massachusetts (800) ACCUTEST, INC. P.O. Box 999 Westford, Massachusetts 01886 (800) 665-2575 MICROBIOLOGY Bacteriology Aerobic Culture and Identification Antibiotic Susceptibility Testing Direct Antigen Detection Gram Stain

More information

Proficiency Testing LABFACTS Requirements for good laboratory practice and COLA Laboratory Accreditation programs are underlined.

Proficiency Testing LABFACTS Requirements for good laboratory practice and COLA Laboratory Accreditation programs are underlined. Proficiency Testing LABFACTS 8 INTRODUCTION Proficiency testing (PT) is an important aspect of an overall quality assurance program. PT serves as an external check to verify the accuracy of a 's results

More information

M E D I C A L L A B O R A T O R Y

M E D I C A L L A B O R A T O R Y M E D I C A L L A B O R A T O R Y E V A L U A T I O N PARTICIPANT SUMMARY 2 0 1 5 Immunology MLE-M2 Total Commitment to Education and Service Provided by ACP, Inc. Table of Contents Evaluation Criteria...

More information

M E D I C A L L A B O R A T O R Y

M E D I C A L L A B O R A T O R Y M E D I C A L L A B O R A T O R Y E V A L U A T I O N PARTICIPANT SUMMARY 2 0 1 5 Immunology MLE-M1 Total Commitment to Education and Service Provided by ACP, Inc. Table of Contents Evaluation Criteria...

More information

M E D I C A L L A B O R A T O R Y

M E D I C A L L A B O R A T O R Y M E D I C A L L A B O R A T O R Y E V A L U A T I O N PARTICIPANT SUMMARY 2 0 1 7 Immunology 2017 MLE-M3 Total Commitment to Education and Service Provided by ACP, Inc. Table of Contents Evaluation Criteria...

More information

M E D I C A L L A B O R A T O R Y

M E D I C A L L A B O R A T O R Y M E D I C A L L A B O R A T O R Y E V A L U A T I O N PARTICIPANT SUMMARY 2 0 1 6 Immunology 2016 MLE-M3 Total Commitment to Education and Service Provided by ACP, Inc. Table of Contents Evaluation Criteria...

More information

REFERENCE LABORATORY. Regular Hours - Monday through Friday 8:00 AM to 4:00 PM. On-Call Staff - Evenings, Nights, Weekend and Holidays.

REFERENCE LABORATORY. Regular Hours - Monday through Friday 8:00 AM to 4:00 PM. On-Call Staff - Evenings, Nights, Weekend and Holidays. I. REFERENCE LABORATORY HOURS OF OPERATION: Regular Hours - Monday through Friday 8:00 AM to 4:00 PM. On-Call Staff - Evenings, Nights, Weekend and Holidays. All Reference Lab procedures are subject to

More information

M E D I C A L L A B O R A T O R Y

M E D I C A L L A B O R A T O R Y M E D I C A L L A B O R A T O R Y E V A L U A T I O N PARTICIPANT SUMMARY 2 0 1 7 Immunology 2017 MLE-M1 Total Commitment to Education and Service Provided by ACP, Inc. Table of Contents Evaluation Criteria...

More information

M E D I C A L L A B O R A T O R Y

M E D I C A L L A B O R A T O R Y M E D I C A L L A B O R A T O R Y E V A L U A T I O N PARTICIPANT SUMMARY 2 0 1 3 Total Commitment to Education and Service Provided by ACP, Inc. Immunology MLE-M2 Table of Contents Evaluation Criteria...

More information

M E D I C A L L A B O R A T O R Y

M E D I C A L L A B O R A T O R Y M E D I C A L L A B O R A T O R Y E V A L U A T I O N PARTICIPANT SUMMARY 2 0 1 4 Immunology MLE-M1 Total Commitment to Education and Service Provided by ACP, Inc. Table of Contents Evaluation Criteria...

More information

M E D I C A L L A B O R A T O R Y

M E D I C A L L A B O R A T O R Y M E D I C A L L A B O R A T O R Y E V A L U A T I O N PARTICIPANT SUMMARY 2 0 1 1 Total Commitment to Education and Service Provided by ACP, Inc. Immunology MLE M1 Table of Contents 2011 Evaluation Criteria...

More information

Primary Sample Manual Infectious Serology Issue No Effective Date: 20/09/17 Page 1 of 15 EUROFINS BIOMNIS

Primary Sample Manual Infectious Serology Issue No Effective Date: 20/09/17 Page 1 of 15 EUROFINS BIOMNIS Issue No. 2.02 Effective Date: 20/09/17 Page 1 of 15 Written / Revised By: Dr. Mike Louw, Medical Director Date: Reviewed By: Date: Dr. Sinead Kelly, Infectious Serology Consultant Authorised By: Jean-Sébastien

More information

q,a;e Fc ) ORIGINAL EVALUATION. FH9-B 2017 Hematology Auto Differentials, FH9

q,a;e Fc ) ORIGINAL EVALUATION. FH9-B 2017 Hematology Auto Differentials, FH9 etiee INSTITUTION: ATTENTION: CAP NUMBER: KIT INFORMATION: COPIED TO: LKF Laboratorium fur Klinische Forschung GmbH Schwentinental GE 24223 Volker El-Samalouti PhD 7234136-01 Kit# 1 Kit ID: Kit Mailed:

More information

Transfusion Reactions. Directed by M-azad March 2012

Transfusion Reactions. Directed by M-azad March 2012 Transfusion Reactions Directed by M-azad March 2012 Transfusion Reactions are Adverse reactions associated with the transfusion of blood and its components Transfusion reactions Non-threatening to fatal

More information

Blood transfusion. Dr. J. Potgieter Dept. of Haematology NHLS - TAD

Blood transfusion. Dr. J. Potgieter Dept. of Haematology NHLS - TAD Blood transfusion Dr. J. Potgieter Dept. of Haematology NHLS - TAD General Blood is collected from volunteer donors >90% is separated into individual components and plasma Donors should be: healthy, have

More information

ORIGINAL EVALUATION. FH9-C 2017 Hematology Auto Differentials, FH9

ORIGINAL EVALUATION. FH9-C 2017 Hematology Auto Differentials, FH9 ft Cit e * 4> ee e e e *111» * * PAT H 0 LO GI STS INSTITUTION: ATTENTION: CAP NUMBER: KIT INFORMATION: COPIED TO: LKF Laboratorium fur Klinische Forschung GmbH Schwentinental GE 24223 Volker El-Samalouti

More information

EC CERTIFICATE. National Institute for Biological Standards and Control (NIBSC) Blanche Lane South Mimms Potters Bar Hertfordshire EN6 3QG UK

EC CERTIFICATE. National Institute for Biological Standards and Control (NIBSC) Blanche Lane South Mimms Potters Bar Hertfordshire EN6 3QG UK National Institute for Biological Standards and Control (NIBSC) EC Certificate - Full Quality Assurance System Approval Certificate Annex IV (excluding sections 4 and 6) of Council Directive 98/79/EC on

More information

Uniplas Das Einheitsplasma für jedermann

Uniplas Das Einheitsplasma für jedermann Uniplas Das Einheitsplasma für jedermann Petra Jilma, MD Medical University of Vienna, Vienna, Austria ÖGBT, Juni 2013 UNIPLAS Universal plasma is a novel, blood group independent human pooled plasma and

More information

TRANSFUSION REACTIONS

TRANSFUSION REACTIONS 14 TRANSFUSION REACTIONS 14.1 INTRODUCTION Transfusion of blood and blood products are reported to cause reactions during or after procedure specially in patients who receive multiple transfusions. These

More information

HOVON 141 CLL. Version 3, 25JUL2018. Table Required investigations at entry, during treatment and during follow up.

HOVON 141 CLL. Version 3, 25JUL2018. Table Required investigations at entry, during treatment and during follow up. Table 10.2.1 Required investigations at entry, during treatment and during follow up At entry 1 each induction cycle cycle 2 Cycle 3 day 8 and 15 Cycle 4 day1 and 6 cycle 9 day 15 of cycle 15 9 cycle 15:

More information

Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK

Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK Schedule of Accreditation 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK National Infection Service, Public Health England Colindale 61 Colindale Avenue London NW9 5EQ Contact: Dr Sanjiv

More information

Controls & Calibrators. Disease Quality Controls

Controls & Calibrators. Disease Quality Controls Controls & Calibrators Infectious Disease Quality Controls Infectious Disease Quality Controls A broad selection of controls designed to monitor assay precision of hepatitis, retrovirus, sexually transmitted

More information

AccuSet HBV Worldwide Performance Panel

AccuSet HBV Worldwide Performance Panel PACKAGE INSERT 0805-033 INTENDED USE The is intended for use by diagnostic manufacturers, researchers, and clinical laboratories to develop, evaluate, or troubleshoot HBV test methods. Characterized samples

More information

QUALITY CONTROL Infectious Disease

QUALITY CONTROL Infectious Disease QUALITY CONTROL Infectious Disease 1 Infectious Disease Quality Control The human based material used in the production of our Quality Controls is sourced from the Taiwan Blood Services Foundation (TBSF).

More information

Test Name Results Units Bio. Ref. Interval

Test Name Results Units Bio. Ref. Interval LL - LL-ROHINI (NATIONAL REFERENCE 135091606 Age 24 Years Gender Male 30/8/2017 92800AM 30/8/2017 94631AM 31/8/2017 90306AM Ref By Final HEATITIS A & B VIRUS EVALUATION HEATITIS A ANTIBODY (ANTI HAV),

More information

The testing of Donated Blood and Components at NHSBT

The testing of Donated Blood and Components at NHSBT The testing of Donated Blood and Components at NHSBT NHSBT is responsible for collecting all donated blood and platelets in England, then processing into components before issuing to client hospitals.

More information

NLBCP-017 INDIRECT ANTIGLOBULIN CROSSMATCH TUBE METHOD. Issuing Authority

NLBCP-017 INDIRECT ANTIGLOBULIN CROSSMATCH TUBE METHOD. Issuing Authority Government of Newfoundland and Labrador Department of Health and Community Services Provincial Blood Coordinating Program INDIRECT ANTIGLOBULIN CROSSMATCH TUBE METHOD Office of Administrative Responsibility

More information

READ HIGHLIGHTED CHANGES

READ HIGHLIGHTED CHANGES BIO-FLASH anti-hbs 3000-8581 100 tests The BIO-FLASH anti-hbs is a fully automated chemiluminescent simultaneous immunoassay for quantitative measurement of antibodies to Hepatitis B surface antigen (anti-hbs)

More information

SOLE-SOURCE DETERMINATION

SOLE-SOURCE DETERMINATION SOLE-SOURCE DETERMINATION The Purchasing Division has been requested to approve a sole source purchase for the commodity or service described below. Pursuant to West Virginia Code 5A-3-10c, the Purchasing

More information

Diagnostic Methods of HBV infection. Zohreh Sharifi,ph.D of Virology Research center, Iranian Blood Transfusion Organization (IBTO)

Diagnostic Methods of HBV infection. Zohreh Sharifi,ph.D of Virology Research center, Iranian Blood Transfusion Organization (IBTO) Diagnostic Methods of HBV infection Zohreh Sharifi,ph.D of Virology Research center, Iranian Blood Transfusion Organization (IBTO) Hepatitis B-laboratory diagnosis Detection of HBV infection involves

More information

Schedule of Accreditation

Schedule of Accreditation Schedule of Accreditation Organisation Name National Virus Reference Laboratory INAB Reg No 326MT Contact Name Eimear Malone Address University College Dublin, Belfield, Dublin Contact Phone No 01-7161319

More information

Lab Guide Blood Bank Section Lab Guide

Lab Guide Blood Bank Section Lab Guide Lab Guide - 2018 Blood Bank Section Lab Guide 1.1. Laboratory Tests Provided by Blood Banks: ABO/Rh Typing Neonates Less than 4months =1ml Children 2Years and above including adults =4ml Routine: within

More information

2. Liver blood tests and what they mean p2 Acute and chronic liver screen

2. Liver blood tests and what they mean p2 Acute and chronic liver screen Hepatology referral pathways for GP 1 Scope For use within hepatology Contents 2. Liver blood tests and what they mean p2 Acute and chronic liver screen p2 Common reasons for hepatology referral 3. Raised

More information

Test Name Results Units Bio. Ref. Interval

Test Name Results Units Bio. Ref. Interval LL - LL-ROHINI (NATIONAL REFERENCE 135091650 Age 49 Years Gender Male 29/8/2017 120000AM 29/8/2017 100248AM 29/8/2017 105306AM Ref By Final HEATITIS, VIRAL, COMREHENSIVE ANEL HEATITIS A ANTIBODY (ANTI

More information

HEPATITIS B NON-IMMEDIATE NOTIFICATION EPIDEMIOLOGY PROGRAM

HEPATITIS B NON-IMMEDIATE NOTIFICATION EPIDEMIOLOGY PROGRAM HEPATITIS B NON-IMMEDIATE NOTIFICATION EPIDEMIOLOGY PROGRAM Event Name: Event Time Period: ACUTE Clinical Presentation (CDC 2012): CDC Event (2012): HEPB Lifelong immunity An acute illness with a discrete

More information

مواجهه شغلی HBV HCV HIV

مواجهه شغلی HBV HCV HIV مواجهه شغلی HBV HCV HIV شبكھ جھاني تزریق ایمن تخمین مي زندكھ میلیاردتزریق سالیانھ دردنیاانجام مي شود. تقریبا شانزده خیلي ازاین تزریقھا غیرضروري داروھاي خوراكي بھتر اثرمي كنند بخصوص است وقتي كھ درسال 2000

More information

Answering your daily challenges. in the ELISA technology I N FECTI OUS DISEASES. bioelisa

Answering your daily challenges. in the ELISA technology I N FECTI OUS DISEASES. bioelisa Answering your daily challenges in the ELISA technology I N FECTI OUS DISEASES bioelisa RETROVIRUS HIV is the cause of the most important global pandemic. Due to the lack of vaccination, early diagnosis

More information

Essentials of Blood Group Antigens and Antibodies

Essentials of Blood Group Antigens and Antibodies Essentials of Blood Group Antigens and Antibodies Non-Medical Authorisation of blood Components Nov 2017 East Midlands Regional Transfusion Committee Transfusion Terminology Antigens and Antibodies Antibodies

More information

PILOT STUDY OF ANTIGEN MATCHING FOR AUTOIMMUNE HEMOLYTIC ANEMIA

PILOT STUDY OF ANTIGEN MATCHING FOR AUTOIMMUNE HEMOLYTIC ANEMIA PILOT STUDY OF ANTIGEN MATCHING FOR AUTOIMMUNE HEMOLYTIC ANEMIA Sharon Rice & Fred Plapp Saint Luke s Hospital Kansas City, MO CENTRALIZED TRANSFUSION SERVICE Antibody identification Antibody titer Antigen

More information

Probability of false initial and repeat ID-NAT reactive donations. Marion Vermeulen IPFA Rome 2014

Probability of false initial and repeat ID-NAT reactive donations. Marion Vermeulen IPFA Rome 2014 Probability of false initial and repeat ID-NAT reactive donations Marion Vermeulen IPFA Rome 2014 Overview of SANBS SANBS is a non profit organization Provides a vein to vein blood transfusion service

More information

Management of platelet refractory patients, why does your patient keep on bleeding? Dr Colin Brown, H&I Dept, NHSBT Colindale

Management of platelet refractory patients, why does your patient keep on bleeding? Dr Colin Brown, H&I Dept, NHSBT Colindale Management of platelet refractory patients, why does your patient keep on bleeding? Dr Colin Brown, H&I Dept, NHSBT Colindale Pooled Platelets (Buffy Coat Derived) Adult dose from 4 ABO-identical donors

More information

الحترمونا من خري الدعاء

الحترمونا من خري الدعاء الحترمونا من خري الدعاء Instructions for candidates The examination consists of 30 multiple choice questions, each divided into 5 different parts. Each part contains a statement which could be true or

More information

Guidance for Industry

Guidance for Industry Guidance for Industry Advisement for the Use of Gen-Probe Procleix Ultrio Plus Assay for NAT Testing on Cadaveric Donors Release Date: 08/03/14 American Medical Education and Research Association 4757

More information

It s not just allo-antibodies that a red cell transfusion can stimulate

It s not just allo-antibodies that a red cell transfusion can stimulate It s not just allo-antibodies that a red cell transfusion can stimulate Associate Professor Ralph Green Laboratory Medicine RMIT University Melbourne, Australia Transfusion practice Minimise risk of transmitting

More information

The Hepatitis B-e antigen-positive

The Hepatitis B-e antigen-positive The Hepatitis B-e antigen-positive Dental Student Developing an Equitable Policy Hepatitis B Virus Serology 1 HBsAg A protein on the surface of HBV; it can be detected in high levels in serum during acute

More information

Frequency of occult hepatitis B in HBsAg seronegative blood donors in a tertiary care hospital in kerala,south India.

Frequency of occult hepatitis B in HBsAg seronegative blood donors in a tertiary care hospital in kerala,south India. Frequency of occult hepatitis B in HBsAg seronegative blood donors in a tertiary care hospital in kerala,south India. Cinzia Keechilot, Veena Shenoy 1,V Anil kumar 2,Lalita Biswas 3. MBBS student * Transfusion

More information

DS-EIA-ANTI-HIV-UNIF (Ab) I DS-EIA-ANTI-HIV-UNIF (Ab) I DS-EIA-ANTI-HIV-UNIF (Ab) I

DS-EIA-ANTI-HIV-UNIF (Ab) I DS-EIA-ANTI-HIV-UNIF (Ab) I DS-EIA-ANTI-HIV-UNIF (Ab) I * Sensitivity HIV DS-EIA-ANTI-HIV-UNIF (Ab) I-153 96 115 24 DS-EIA-ANTI-HIV-UNIF (Ab) I-150 192 115 24 DS-EIA-ANTI-HIV-UNIF (Ab) I-155 480 115 24 DS-EIA-HIV-AG-SCREEN I-1452 96 115 12 0.025 IU/ml DS-EIA-HIV-AGAB-SCREEN

More information

Blood Component Testing and Labeling

Blood Component Testing and Labeling Blood Component Testing and Labeling Each donor unite must be tested and properly labeled before its release for transfusion. Required Tests: In most blood banks, pretransfusion testing involves determining

More information

TEST REQUEST INFORMATION- VIROLOGY

TEST REQUEST INFORMATION- VIROLOGY Chlamydia/ Gonorrhea Nucleic Acid Amplification VC75 Qualitative Nucleic Acid Amplification SPECIMEN: Genital swab or first catch urine CONTAINER:GEN-PROBE APTIMA 2 Combo swab transport tube or urine transport

More information

Principles of In Vitro Diagnostic (IVD) Medical Devices Classification

Principles of In Vitro Diagnostic (IVD) Medical Devices Classification Technical Reference: TR-006 Date of Issue: 1 Dec. 2009 Principles of In Vitro Diagnostic (IVD) Medical Devices Classification Technical Reference: TR-006 Department of Health The G overnment of the Hong

More information

Reflex Test Protocols

Reflex Test Protocols Blood Bank Prepare RBCs for Transfusion (aka Crossmatch) N/A No Antibody Screen ordered Antibody Screen Direct Antiglobulin Test (DAT) Polyspecific DAT Positive polyspecific DAT IgG DAT, C3 DAT Fetal Cell

More information

Official Journal of the European Communities COMMISSION

Official Journal of the European Communities COMMISSION 16.5.2002 EN Official Journal of the European Communities L 131/17 COMMISSION COMMISSION DECISION of 7 May 2002 on common technical specifications for in vitro-diagnostic medical devices (notified under

More information

AccuVert HBV Seroconversion Panel PHM941(M) ( )

AccuVert HBV Seroconversion Panel PHM941(M) ( ) PACKAGE INSERT PHM941(M) (0605-0061) INTENDED USE PHM941(M) (0605-0061) is a group of serial bleeds from an individual plasma donor during HBV seroconversion. This panel is intended for use by diagnostics

More information

Reflex Test Protocols

Reflex Test Protocols UCH Clinical Laboratory Reflex Test Protocols Blood Bank Prepare RBCs for Transfusion (aka Crossmatch) N/A No Antibody Screen ordered Antibody Screen Direct Antiglobulin Test (DAT) Polyspecific DAT Positive

More information

HEALTH SERVICES POLICY & PROCEDURE MANUAL

HEALTH SERVICES POLICY & PROCEDURE MANUAL PAGE 1 of 5 PURPOSE To provide guidelines on the treatment and care of patients with Hepatitis. POLICY Hepatitis is an injury to hepatic cells and an inflammatory process in the liver. The major causes

More information

Significance of Antibodies and appropriate selection of red cells for transfusion Chris Elliott Haematology Service manager

Significance of Antibodies and appropriate selection of red cells for transfusion Chris Elliott Haematology Service manager Significance of Antibodies and appropriate selection of red cells for transfusion Chris Elliott Haematology Service manager James Cook University Hospital Friarage Hospital Over the next 30 minutes Bit

More information

2. Liver blood tests and what they mean p2 Acute and chronic liver screen

2. Liver blood tests and what they mean p2 Acute and chronic liver screen 1 Scope For use within hepatology Contents 2. Liver blood tests and what they mean p2 Acute and chronic liver screen p2 Common reasons for referral 3. Raised ALT +/- GGT p3 4. Non alcoholic fatty liver

More information

Based in Lyon, France, Alvedia provides a full range of canine, feline, swine & equine diagnostics products since 2004.

Based in Lyon, France, Alvedia provides a full range of canine, feline, swine & equine diagnostics products since 2004. Alvedia is a company specialized in the field of veterinary diagnostics, providing veterinary health professionals with the most advanced and innovative immunochromatographic technology. Based in Lyon,

More information

Innovation in Diagnostics. ToRCH. A complete line of kits for an accurate diagnosis INFECTIOUS ID DISEASES

Innovation in Diagnostics. ToRCH. A complete line of kits for an accurate diagnosis INFECTIOUS ID DISEASES Innovation in Diagnostics ToRCH A complete line of kits for an accurate diagnosis INFECTIOUS ID DISEASES EN TOXOPLASMOSIS Toxoplasmosis is a parasitic disease caused by with the obligate intracellular

More information

8/28/2018. Disclosures. Objectives. None. Automation to PreciseType and Everything in Between

8/28/2018. Disclosures. Objectives. None. Automation to PreciseType and Everything in Between Automation to PreciseType and Everything in Between Jessie Singer MT(ASCP) Transfusion Medicine Children s Hospital Los Angeles None Disclosures Objectives Describe the application of molecular testing

More information

Automation to PreciseType and Everything in Between. Jessie Singer MT(ASCP) Transfusion Medicine Children s Hospital Los Angeles

Automation to PreciseType and Everything in Between. Jessie Singer MT(ASCP) Transfusion Medicine Children s Hospital Los Angeles Automation to PreciseType and Everything in Between Jessie Singer MT(ASCP) Transfusion Medicine Children s Hospital Los Angeles None Disclosures Objectives Describe the application of molecular testing

More information

H. PYLORI AB, IGG HPYL

H. PYLORI AB, IGG HPYL H. PYLORI AB, IGG HPYL Specimen Required: 3 ml blood, Serum gel tube Analytical Time: 1 day CPT Code: 86677 HAPTOGLOBIN HAP Specimen Required: 1.5 ml blood, gel tube Reference Range: 30-200 mg/dl CPT Code:

More information

Learning Objectives. New HIV Testing Algorithm from CDC. Overview of HIV infection and disease 3/15/2016

Learning Objectives. New HIV Testing Algorithm from CDC. Overview of HIV infection and disease 3/15/2016 New HIV Testing Algorithm from CDC ASCLS-Michigan March 31, 2016 Dr. Kathleen Hoag Learning Objectives Following attendance and review of material provided, attendees will be able to: 1. Describe the new

More information

The Alphabet Soup of Viral Hepatitis Testing

The Alphabet Soup of Viral Hepatitis Testing The Alphabet Soup of Viral Hepatitis Testing August 18, 2011 Patricia Slev, PhD, DABCC Medical Director, Serologic Hepatitis and Retrovirus Laboratory, ARUP Laboratories Assistant Professor of Pathology,

More information

This document is meant purely as a documentation tool and the institutions do not assume any liability for its contents

This document is meant purely as a documentation tool and the institutions do not assume any liability for its contents 2002D0364 EN 01.07.2012 002.001 1 This document is meant purely as a documentation tool and the institutions do not assume any liability for its contents B COMMISSION DECISION of 7 May 2002 on common technical

More information

Passenger Lymphocyte Syndrome (case presentation) Dr. Namal Bandara Kings College Hospital

Passenger Lymphocyte Syndrome (case presentation) Dr. Namal Bandara Kings College Hospital Passenger Lymphocyte Syndrome (case presentation) Dr. Namal Bandara Kings College Hospital Case history 24year Female Known Patient with Wilsons Disease DBD donor Liver Transplantation done on 15/08/2016

More information

Structure and duties of Blood service

Structure and duties of Blood service NATIONAL CENTER FOR TRANSFUSION MEDICINE Prevalence of infectious diseases among Mongolian blood donors Namjil Erdenebayar General director of The National Center for Transfusion Medicine, Mongolia NCTM,

More information

Immunohaematology: a branch of immunology that deals with the immunologic properties of blood.

Immunohaematology: a branch of immunology that deals with the immunologic properties of blood. 1 Immunohaematology: a branch of immunology that deals with the immunologic properties of blood. The red blood cells have on their surface hundreds of antigens and according to the antigen on their surface

More information

Direct Antiglobulin Test (DAT)

Direct Antiglobulin Test (DAT) Exercise 8 Direct Antiglobulin Test (DAT) Objectives 1. State the purpose for performing the DAT. 2. State what a positive DAT indicates. 3. List the reagents which are used for performing the DAT. 4.

More information

NAT Screening of Blood Donations in NBC, TRCS

NAT Screening of Blood Donations in NBC, TRCS IPFA/PEI, Italy NAT Screening of Blood Donations in NBC, TRCS 2000-2001 Clinical evaluation using COBAS AmpliiScreen HIV & HCV assays, (MP24) window period rate - 1 : 108,768 for HIV-1 and HCV 2002 Routine

More information

Dr.Rajeshwari Basavanna, Dr.Biju George, Dr.Dolly Daniel Transfusion Medicine and Immunohaematology Department of Haematology CMC Vellore

Dr.Rajeshwari Basavanna, Dr.Biju George, Dr.Dolly Daniel Transfusion Medicine and Immunohaematology Department of Haematology CMC Vellore Dr.Rajeshwari Basavanna, Dr.Biju George, Dr.Dolly Daniel Transfusion Medicine and Immunohaematology Department of Haematology CMC Vellore Background Clinical Severity of disease Autoimmune Haemolytic anaemia

More information

Fifty ways to fail your patient. Haemolytic transfusion reactions

Fifty ways to fail your patient. Haemolytic transfusion reactions Fifty ways to fail your patient Haemolytic transfusion reactions Nearly Fifty ways to fail your patient Haemolytic transfusion reactions Acute haemolytic transfusion reaction (AHTR): definition Fever and

More information

Multichem Infectious Disease QC

Multichem Infectious Disease QC Infectious Disease QC Contents Introduction....3 Quality Control in the Laboratory...4 Infectious Disease (ID) QC....5 Ready-to-use Concept....6 NRL...7 QConnect...8 IAMQC in Collaboration with QConnect....

More information

CDC website:

CDC website: Hepatitis B virus CDC website: http://www.cdc.gov/ncidod/diseases/hepatitis/slideset/hep_b/slide_1.htm Relevance Key Features es of Hepatitis t B Virus 250 million people infected worldwide. In areas of

More information

INVESTIGATION OF ADVERSE TRANSFUSION REACTIONS NLBCP-006. Issuing Authority

INVESTIGATION OF ADVERSE TRANSFUSION REACTIONS NLBCP-006. Issuing Authority Government of Newfoundland and Labrador Department of Health and Community Services Provincial Blood Coordinating Program INVESTIGATION OF ADVERSE TRANSFUSION REACTIONS Office of Administrative Responsibility

More information

AIHA The Laboratory Perspective on Testing. Tom Bullock Joint UK NEQAS (BTLP) & BBTS BBT SIG Annual Meeting 20 th November 2018

AIHA The Laboratory Perspective on Testing. Tom Bullock Joint UK NEQAS (BTLP) & BBTS BBT SIG Annual Meeting 20 th November 2018 AIHA The Laboratory Perspective on Testing Tom Bullock Joint UK NEQAS (BTLP) & BBTS BBT SIG Annual Meeting 20 th November 2018 Auto Immune Haemolytic Anaemia (AIHA) BSH guideline (Hill et al. 2017): AIHA

More information

Brrrr, It s Cold In Here

Brrrr, It s Cold In Here Brrrr, It s Cold In Here Kate Grogan, MD Transfusion Medicine Fellow Physician, BloodworksNW 4/24/15 Patient 20 year old female Viral illness Presents one week later with severe hemolysis Hgb 5.6 Increased

More information

Private Patients Pricelist

Private Patients Pricelist Private Patients Pricelist Valid 1 January 2017-31 December 2017 INF-ACC-006 1043973 Rev 0 (01/06/17) Reg No. 2000/026390/08 Private Diagnostic Services Nappi 10580 Packaging R75.14 R85.66 15016 Low Ionic

More information

Hepatitis A virus (HAV)

Hepatitis A virus (HAV) Volume 3, Issue 1 (Jan 2010) Editor s note Happy New Year and welcome to the first issue of QA Highlights of year 2010! In this issue, we are happy to bring to you Hepatitis Infection and Clinical Detection

More information

Product List Autobio Diagnostics. Autobio. autobio diagnostics an autobio group company

Product List Autobio Diagnostics. Autobio. autobio diagnostics an autobio group company Product List Autobio Diagnostics Autobio.. autobio diagnostics an autobio group company www.autobio-diagnostics.com Autobio Diagnostics Co., Ltd. was established in 1998 and has become one of the largest

More information

See external label 2 C-8 C 96 tests Chemiluminescence. CMV IgM. Cat # Diluted samples, controls & calibrator 100 µl 30 minutes

See external label 2 C-8 C 96 tests Chemiluminescence. CMV IgM. Cat # Diluted samples, controls & calibrator 100 µl 30 minutes DIAGNOSTIC AUTOMATION, INC. 23961 Craftsman Road, Suite D/E/F, Calabasas, CA 91302 Tel: (818) 591-3030 Fax: (818) 591-8383 onestep@rapidtest.com technicalsupport@rapidtest.com www.rapidtest.com See external

More information

Organ Procurement and Transplantation Network

Organ Procurement and Transplantation Network OPTN Organ Procurement and Transplantation Network POLICIES This document provides the policy language approved by the OPTN/UNOS Board at its meeting in June 2015 as part of the Operations and Safety Committee

More information

DIAGNOSTIC AUTOMATION, INC.

DIAGNOSTIC AUTOMATION, INC. DIAGNOSTIC AUTOMATION, INC. 23961 Craftsman Road, Suite E/F, Calabasas, CA 91302 Tel: (818) 591-3030 Fax: (818) 591-8383 onestep@rapidtest.com technicalsupport@rapidtest.com www.rapidtest.com See external

More information

Duration: 12 months May to April

Duration: 12 months May to April SPECIALIST CERTIFICATE IN TRANSFUSION SCIENCE PRACTICE PROGRAMME OF STUDY OVERVIEW Example only Duration: 12 months May to April This document serves as a general programme overview only. To ensure you

More information

See external label 2 C-8 C 96 tests CHEMILUMINESCENCE. CMV IgG. Cat # Step (20-25 C Room temp.) Volume

See external label 2 C-8 C 96 tests CHEMILUMINESCENCE. CMV IgG. Cat # Step (20-25 C Room temp.) Volume DIAGNOSTIC AUTOMATION, INC. 23961 Craftsman Road, Suite D/E/F, Calabasas, CA 91302 Tel: (818) 591-3030 Fax: (818) 591-8383 onestep@rapidtest.com technicalsupport@rapidtest.com www.rapidtest.com See external

More information

Impact of Testing Strategies to Reduce Transmission Risk for HBV. Ravi Reddy, M Vermeulen South African National Blood Service (SANBS) 29 July 2013

Impact of Testing Strategies to Reduce Transmission Risk for HBV. Ravi Reddy, M Vermeulen South African National Blood Service (SANBS) 29 July 2013 Impact of Testing Strategies to Reduce Transmission Risk for HBV Ravi Reddy, M Vermeulen South African National Blood Service (SANBS) 29 July 2013 Overview of SANBS SANBS is a private not for profit company

More information

Immunohematology. IH-QC Modular System. Select. Combine. Control.

Immunohematology. IH-QC Modular System. Select. Combine. Control. Immunohematology IH-QC Modular System Select. Combine. Control. IH-QC Modular System Select. Combine. Control. Transfusion guidelines recommend regular checking of test materials, test methods, local working

More information

MEDICAL DEVICE GUIDANCE DOCUMENT

MEDICAL DEVICE GUIDANCE DOCUMENT MDA/GD/IVD-1 July 2013 First Edition MEDICAL DEVICE GUIDANCE DOCUMENT IN-VITRO DIAGNOSTIC (IVD) MEDICAL DEVICE CLASSIFICATION SYSTEM Medical Device Authority MINISTRY OF HEALTH MALAYSIA Contents Page Preface...

More information

Viral hepatitis. Supervised by: Dr.Gaith. presented by: Shaima a & Anas & Ala a

Viral hepatitis. Supervised by: Dr.Gaith. presented by: Shaima a & Anas & Ala a Viral hepatitis Supervised by: Dr.Gaith presented by: Shaima a & Anas & Ala a Etiology Common: Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E Less common: Cytomegalovirus EBV Rare: Herpes

More information

Impact of multi-dye multiplex technology on testing algorithm

Impact of multi-dye multiplex technology on testing algorithm Impact of multi-dye multiplex technology on testing algorithm Lydia Blanco. Mª Isabel Gonzalez-Fraile Centro de Hemoterapia y Hemodonación de Castilla y León, España TTI EPIDEMIOLOGICAL DATA IN SPAIN NAT

More information

Non-reproductive tissues and cells

Non-reproductive tissues and cells Ministry of Health: Institute for Transplantation and Biomedicine / Colour key VIRAL HIV 1 and HIV 2 Hepatitis B Minimum requirements as set out in Directive 2004/23/EC More stringent - legy binding More

More information

AMERICAN ASSOCIATION OF BIOANALYSTS PROFICIENCY TESTING SERVICE APPLICATION

AMERICAN ASSOCIATION OF BIOANALYSTS PROFICIENCY TESTING SERVICE APPLICATION AMERICAN ASSOCIATION OF BIOANALYSTS PROFICIENCY TESTING SERVICE APPLICATION INSTRUCTIONS FOR USERS OF THE FASTPACK IP SYSTEM SELECT THE FOLLOWING PROGRAM CATALOG NUMBERS BASED ON THE TEST TYPES RUN: TESTING

More information

ELISA kits for infections (HIV; Hepatitis A, B, C, D, E; Syphilis, ToRCH and others), hormone pathologies and tumor markers.

ELISA kits for infections (HIV; Hepatitis A, B, C, D, E; Syphilis, ToRCH and others), hormone pathologies and tumor markers. DSI S.r.l. DSI S.r.l. is one of the European leaders in the field of immunodiagnostic tests manufacturing. We are a research-focused company with the long-term microbiological scientific traditions. Our

More information

Serum Hepatitis B Surface Antigen Levels Help Predict Disease Progression in Patients With Low Hepatitis B Virus Loads. Hepatology Feb 2013

Serum Hepatitis B Surface Antigen Levels Help Predict Disease Progression in Patients With Low Hepatitis B Virus Loads. Hepatology Feb 2013 Serum Hepatitis B Surface Antigen Levels Help Predict Disease Progression in Patients With Low Hepatitis B Virus Loads Hepatology Feb 2013 Hepatitis B Surface Antigen HBsAg is the glycosylated envelope

More information

PATHOLOGY SPECIMEN TUBES QUICK REFERENCE GUIDE : Edition Expires July 2013

PATHOLOGY SPECIMEN TUBES QUICK REFERENCE GUIDE : Edition Expires July 2013 PATHOLOGY SPECIMEN TUBES QUICK REFERENCE GUIDE : 2012 2013 Edition Expires July 2013 FOR THE MOST UP TO DATE INFORMATION AND FOR TESTS THAT ARE NOT LISTED HERE PLEASE CHECK THE INTRANET SITE AT: http://rhhlas26/path_tests/lab_default.asp

More information

Immunohematology (Introduction)

Immunohematology (Introduction) Modified from Serotonin version Immunohematology (Introduction) References: -Blood Groups and Red Cell Antigens (Laura Dean) -Cellular and molecular immunology, 8 th edition Introduction to replace blood

More information